ACMVX
Price
$16.57
Change
+$0.16 (+0.98%)
Updated
Jul 2 closing price
Net Assets
5.7B
VMVAX
Price
$103.69
Change
+$1.01 (+0.98%)
Updated
Jul 2 closing price
Net Assets
36.63B
Interact to see
Advertisement

ACMVX vs VMVAX

ACMVX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
ACMVX vs. VMVAX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACMVX is a StrongBuy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 36.6B vs. ACMVX (5.7B). VMVAX pays higher dividends than ACMVX: VMVAX (1.88) vs ACMVX (1.43). ACMVX was incepted earlier than VMVAX: ACMVX (22 years) vs VMVAX (15 years). ACMVX (0.97) is less costly to investors than VMVAX (0.07). ACMVX is a more actively managed with annual turnover of: 62.00 vs. VMVAX (23.00). ACMVX has a lower initial minimum investment than VMVAX: ACMVX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 19.99 vs. ACMVX (4.19). VMVAX return over 5 years is better than : 42.73 vs. ACMVX (-9.05).
ACMVXVMVAXACMVX / VMVAX
Total Expense Ratio0.970.071,386%
Annual Report Gross Expense Ratio0.970.071,386%
Fund Existence22 years15 years-
Gain YTD12.98212.951100%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.7B36.6B16%
Annual Yield % from dividends1.431.8876%
Returns for 1 year4.1919.9921%
Returns for 3 years10.0444.6622%
Returns for 5 years-9.0542.73-21%
Returns for 10 years20.03128.2916%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDVIX25.580.17
+0.67%
AXS FTSE Vntr Cptl RetTrckr I
PRWLX17.920.11
+0.62%
Principal Diversified Intl A
LCCCX33.250.12
+0.36%
Columbia Contrarian Core C
FFAQX18.840.02
+0.11%
Franklin Global Allocation R6
MASGX19.69-0.52
-2.57%
Matthews Emerging Markets Sust Fut Inv